Alliance Blog IRP for Medicare? Drastic change to US policy means new mitigation strategies for pharma

PRICENTRIC BRIEF: President Trump suggest the establishment of a formal IRP system to curb rising Medicare costs The CMS proposed an IRP scheme, covering a handful of European countries where target drug prices are collectively 44% lower Additional changes include switching physician reimbursement from a percentage to a flat fee and the allowance of private-sector [...]The post IRP for Medicare? Drastic change to US policy means new mitigation strategies for pharma appeared first on Alliance Life Sciences.